MOTS-c

What it is

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a mitochondrial-derived peptide encoded in the 12S rRNA region of mitochondrial DNA. It acts as a mitochondrial signal peptide that translocates to the nucleus under metabolic stress, where it activates the AMPK (AMP-activated protein kinase) pathway. AMPK is the body's master metabolic regulator — switching on fat oxidation, improving glucose uptake, and enhancing mitochondrial biogenesis.

Glucose metabolism improves, particularly in muscle tissue. Fat oxidation increases. Exercise performance and endurance capacity rise. Inflammatory markers associated with metabolic dysfunction decline. The effect is particularly notable under metabolic stress conditions — fasting, exercise, or carbohydrate restriction.

• Improved insulin sensitivity and glucose tolerance in animal and early human studies
• Increased skeletal muscle glucose uptake via AMPK activation
• Reduced diet-induced and age-related obesity in preclinical models
• Enhanced exercise capacity and mitochondrial function
• Anti-ageing effects on cellular stress pathways

Who it's for

• Insulin resistance and metabolic syndrome
• Athletic performance and endurance improvement
• Metabolic anti-ageing protocols
• Adjunct to GLP-1 or GIP agonist protocols for enhanced metabolic benefit

• Those with a history of autoimmune conditions — AMPK modulation may have immune implications (limited data)
• Pregnancy (insufficient safety data)
• Those expecting single-agent significant weight loss — MOTS-c is metabolic support, not a primary fat-loss compound

Protocol guidance

Contraindications & cautions

• Human clinical trial data is still early-stage — use within research protocols
• Exercise potentiates the effect — combine with regular training for best outcomes
• Avoid concurrent use with medications that strongly modulate AMPK (e.g., metformin) without practitioner guidance

Pairs well with

Research